Form 4 for SILO Silo Pharma, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-15 · accession 0001213900-25-122429 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-16 | 2025-12-15 | SILO | Weisblum Eric | CEO, Dir | P - Purchase | $0.415 | +5,000 | 214.4K | +2% | +$2,075 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | P | A | 2,500 | $0.42 | 216,932 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-15 | P | A | 2,500 | $0.41 | 214,432 | D | — | — |